| scholarly article | Q13442814 |
| P50 | author | Shenia Patterson | Q87057044 |
| Jonathan Thon | Q87057046 | ||
| Joseph E. Italiano | Q125127482 | ||
| Katya Ravid | Q38329138 | ||
| Philip C. Trackman | Q40642250 | ||
| Shinobu Matsuura | Q55154914 | ||
| P2093 | author name string | Nikolaos Papadantonakis | |
| Paul Toselli | |||
| Alexia Eliades | |||
| Milka Koupenova | |||
| Rongjuan Mi | |||
| P2860 | cites work | The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes | Q22299206 |
| Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2 | Q24568313 | ||
| Glycoprotein VI-dependent and -independent pathways of thrombus formation in vivo | Q24669536 | ||
| Abnormalities of GATA-1 in megakaryocytes from patients with idiopathic myelofibrosis | Q24671505 | ||
| Structural basis of collagen recognition by integrin alpha2beta1 | Q27622310 | ||
| Leukocyte-platelet interaction in patients with essential thrombocythemia and polycythemia vera | Q28174281 | ||
| A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera | Q28241887 | ||
| The role of lysyl oxidase in SRC-dependent proliferation and metastasis of colorectal cancer | Q28304399 | ||
| Glycoprotein VI but not alpha2beta1 integrin is essential for platelet interaction with collagen | Q28364081 | ||
| A lineage-selective knockout establishes the critical role of transcription factor GATA-1 in megakaryocyte growth and platelet development | Q28591602 | ||
| A gain-of-function mutation of JAK2 in myeloproliferative disorders | Q29618851 | ||
| Molecular priming of Lyn by GPVI enables an immune receptor to adopt a hemostatic role | Q30157042 | ||
| Ferric chloride-induced murine carotid arterial injury: A model of redox pathology | Q30585424 | ||
| Elucidation of the phenotypic, functional, and molecular topography of a myeloerythroid progenitor cell hierarchy. | Q33326050 | ||
| A lineage-restricted and divergent beta-tubulin isoform is essential for the biogenesis, structure and function of blood platelets | Q33337405 | ||
| Mutation in beta1-tubulin correlates with macrothrombocytopenia in Cavalier King Charles Spaniels | Q33379541 | ||
| An image-based screen identifies a small molecule regulator of megakaryopoiesis | Q33402801 | ||
| Identification of an acquired JAK2 mutation in polycythemia vera | Q33947635 | ||
| Integrin α2-Deficient Mice Develop Normally, Are Fertile, but Display Partially Defective Platelet Interaction with Collagen | Q57339936 | ||
| Platelet turnover, coagulation factors, and soluble markers of platelet and endothelial activation in essential thrombocythemia: Relationship with thrombosis occurrence andJAK2 V617F allele burden | Q61914419 | ||
| Myeloproliferative Disease: Markers of Endothelial and Platelet Status in Patients with Essential Thrombocythemia and Polycythemia Vera | Q74000559 | ||
| Increased soluble and platelet-associated CD40 ligand in essential thrombocythemia and reactive thrombocytosis | Q77768132 | ||
| Collagen-platelet interaction: Gly-Pro-Hyp is uniquely specific for platelet Gp VI and mediates platelet activation by collagen | Q77792604 | ||
| Pf4-Cre transgenic mice allow the generation of lineage-restricted gene knockouts for studying megakaryocyte and platelet function in vivo | Q79220440 | ||
| Distinct antithrombotic consequences of platelet glycoprotein Ibalpha and VI deficiency in a mouse model of arterial thrombosis | Q80233007 | ||
| Role of lysyl oxidases in neointima development in vascular allografts | Q84532601 | ||
| Myeloproliferative neoplasms: molecular pathophysiology, essential clinical understanding, and treatment strategies | Q34158356 | ||
| Increased thromboxane biosynthesis in patients with polycythemia vera: evidence for aspirin-suppressible platelet activation in vivo | Q34237772 | ||
| Some speculations on the myeloproliferative syndromes. | Q34296252 | ||
| Control of megakaryocyte expansion and bone marrow fibrosis by lysyl oxidase | Q35144992 | ||
| JAK-STAT pathway activation in malignant and nonmalignant cells contributes to MPN pathogenesis and therapeutic response | Q35163764 | ||
| The role of collagen in thrombosis and hemostasis | Q35752946 | ||
| Properties and Function of Lysyl Oxidase | Q36520735 | ||
| Future innovations in anti-platelet therapies. | Q36753593 | ||
| Fundamental differences in endoreplication in mammals and Drosophila revealed by analysis of endocycling and endomitotic cells | Q36915426 | ||
| Lysyl oxidase binds transforming growth factor-beta and regulates its signaling via amine oxidase activity. | Q36990183 | ||
| Platelet receptors and signaling in the dynamics of thrombus formation. | Q37175605 | ||
| Platelet size and density affect shear-induced thrombus formation in tortuous arterioles | Q37270256 | ||
| JAK2V617F leads to intrinsic changes in platelet formation and reactivity in a knock-in mouse model of essential thrombocythemia | Q37349414 | ||
| Distinct spatio-temporal Ca2+ signaling elicited by integrin alpha2beta1 and glycoprotein VI under flow. | Q37372846 | ||
| Selective targeting of gene products with the megakaryocyte platelet factor 4 promoter | Q37408497 | ||
| Antiplatelet therapy in the management of cardiovascular disease in patients with CKD: what is the evidence? | Q38048245 | ||
| Thrombosis in myeloproliferative neoplasms | Q38194509 | ||
| Brief report: lysyl oxidase is a potential biomarker of fibrosis in systemic sclerosis | Q39244065 | ||
| The expression of lysyl-oxidase gene family members in myeloproliferative neoplasms | Q39451293 | ||
| Uric acid increases fibronectin synthesis through upregulation of lysyl oxidase expression in rat renal tubular epithelial cells | Q39702401 | ||
| Rap1b is critical for glycoprotein VI-mediated but not ADP receptor-mediated alpha2beta1 activation | Q42079343 | ||
| Hemostatic disorders in a JAK2V617F-driven mouse model of myeloproliferative neoplasm | Q42189605 | ||
| GPVI and alpha2beta1 play independent critical roles during platelet adhesion and aggregate formation to collagen under flow | Q42194347 | ||
| Lysyl oxidase oxidizes cell membrane proteins and enhances the chemotactic response of vascular smooth muscle cells | Q42423477 | ||
| Calreticulin mutation-specific immunostaining in myeloproliferative neoplasms: pathogenetic insight and diagnostic value | Q42870482 | ||
| Integrin alpha2beta1 mediates outside-in regulation of platelet spreading on collagen through activation of Src kinases and PLCgamma2. | Q42917596 | ||
| Development of myelofibrosis in mice genetically impaired for GATA-1 expression (GATA-1(low) mice). | Q44083612 | ||
| Platelet activation and inhibition in polycythemia vera and essential thrombocythemia | Q44117506 | ||
| Lysyl oxidase expression in a rat model of arterial balloon injury. | Q44952418 | ||
| Principal role of glycoprotein VI in alpha2beta1 and alphaIIbbeta3 activation during collagen-induced thrombus formation | Q44961840 | ||
| Increased platelet and leukocyte activation as contributing mechanisms for thrombosis in essential thrombocythemia and correlation with the JAK2 mutational status. | Q46930457 | ||
| Increased thromboxane biosynthesis in essential thrombocythemia. | Q51036158 | ||
| Coronary heart disease is associated with mean platelet volume in type 2 diabetic patients. | Q53320457 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | thrombosis | Q261327 |
| P304 | page(s) | 1493-1501 | |
| P577 | publication date | 2016-01-11 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | Lysyl oxidase is associated with increased thrombosis and platelet reactivity | |
| P478 | volume | 127 |
| Q41480921 | A new path to platelet production through matrix sensing. |
| Q104072365 | Cancer and thrombosis: new insights to an old problem |
| Q93152908 | Emerging Factors Implicated in Fibrotic Organ-Associated Thrombosis: The Case of Two Organs |
| Q90725298 | Emerging Roles of Lysyl Oxidases in the Cardiovascular System: New Concepts and Therapeutic Challenges |
| Q33784320 | HPW-RX40 prevents human platelet activation by attenuating cell surface protein disulfide isomerases |
| Q39253646 | Lysyl Oxidase: Its Diversity in Health and Diseases |
| Q92666152 | Lysyl oxidase induces epithelial-mesenchymal transition and predicts intrahepatic metastasis of hepatocellular carcinoma |
| Q91999628 | Mechanism for oral tumor cell lysyl oxidase like-2 in cancer development: synergy with PDGF-AB |
| Q92915916 | N-acetylcysteine inhibits thrombosis in a murine model of myeloproliferative neoplasm |
| Q47322580 | Targeting STUB1-tissue factor axis normalizes hyperthrombotic uremic phenotype without increasing bleeding risk. |
| Q90862882 | The interrelationship between cerebral ischemic stroke and glioma: a comprehensive study of recent reports |
| Q48106053 | The role of extracellular matrix stiffness in megakaryocyte and platelet development and function. |
| Q48311474 | Upregulation of lysyl oxidase and adhesion to collagen of human megakaryocytes and platelets in primary myelofibrosis |
| Q48224247 | Uremic Solute-Aryl Hydrocarbon Receptor-Tissue Factor Axis Associates with Thrombosis after Vascular Injury in Humans |
Search more.